Cannabis and Parkinson's Disease



Parkinson’s illness, likewise referred to as PD, is the 2nd most usual neurodegenerative condition. The illness is defined by a loss of dopamine-producing nerve cells in the substantia nigra, which is a location of the mind in charge of motion. Marijuana, especially CBD, has actually revealed assurance in dealing with several of the signs of PD. In this video clip we will certainly specify Parkinson’s illness as well as marijuana, discuss exactly how marijuana can aid with PD, as well as doctor point of views on suggesting marijuana.

This video clip was developed by Debunking Medication trainees Simran Matharu, Mahek Minhas as well as Micaela McNulty in cooperation with the McMaster Demystifying Medication Program

Copyright McMaster College 2021

For more details see:

www150.statcan.gc.ca/n1/pub/82-003-x/2014011/article/14112-eng.htm

Time Stamps:

Introduction/What is Parkinson’s Illness? → 00:00 – 01:23

What is Marijuana? → 01:24 – 02:34

Just How Can Marijuana Assist with Parkinson’s? → 02:35 – 05:09

Doctor Point of views → 05:10 – 07:19

Final thought → 07:20 – 07:52

Referrals:

Bega, D., Simuni, T., Okun, M. S., Chen, X., & Schmidt, P. (2016 ). Medical marijuana for Parkinson’s illness: Practices, ideas, as well as perspectives amongst suppliers at nationwide Parkinson Structure facilities of quality. Activity Disorders Scientific Technique, 4( 1 ), 90-95.

Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Pisarev, V. M., Tsiperson, V., Nemachek, C., Ciborowski, P., Przedborski, S., Mosley, R. L., & Gendelman, H. E. (2008 ). Nitrated alpha-synuclein resistance increases deterioration of nigral dopaminergic nerve cells. PloS one, 3( 1 ), e1376.

Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2009 ). The endocannabinoid system as a target for the therapy of marijuana dependancy. Neuropharmacology, 56, 235– 243.

de Lau, L. M., & Breteler, M. M. (2006 ). Public health of Parkinson’s illness. The Lancet Neurology, 5( 6 ), 525– 535.

Edelstein, O. E., Wacht, O., Isralowitz, R., Reznik, A., & Bachner, Y. G. (2020 ). Ideas as well as perspectives of graduate gerontology trainees regarding clinical cannabis usage for Alzheimer’s as well as Parkinson’s illness. Corresponding Treatments in Medication, 52, 102418.

Gardiner, K. M., Singleton, J. A., Sheridan, J., Kyle, G. J., & Nissen, L. M. (2019 ). Wellness specialist ideas, expertise, as well as worries bordering medical marijuana– An organized testimonial. PLOS ONE, 14( 5 ), e0216556.

Hauser, R. A., Rascol, O., Korczyn, A. D., Jon Stoessl, A., Watts, R. L., Poewe, W., De Deyn, P. P., & Lang, A. E. (2007 ). Ten-year follow-up of Parkinson’s illness individuals randomized to preliminary treatment with ropinirole or levodopa. Activity conditions: main journal of the Activity Problem Culture, 22( 16 ), 2409– 2417.

Jankovic, J. (2008 ). Parkinson’s illness: Scientific attributes as well as medical diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79( 4 ), 368– 376.

Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., Gunasekaran, N., Karl, T., Long, L. E., Huang, X.-F., Liu, K., Arnold, J. C., & McGregor, I. S. (2011 ). Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioral results as well as changes THC pharmacokinetics throughout intense as well as persistent therapy in teen rats. Psychopharmacology, 218( 2 ), 443– 457.

Lang, A. E., & Lozano, A. M. (1998 ). Parkinson’s Illness. New England Journal of Medication, 339( 16 ), 1130– 1143.

Laun, A. S., & Track, Z. H. (2017 ). GPR3 as well as GPR6, unique molecular targets for cannabidiol. Biochemical as well as biophysical research study interactions, 490( 1 ), 17– 21.

Marras, C., Beck, J. C., Arbor, J. H., Roberts, E., Ritz, B., Ross, G. W., Abbott, R. D., Savica, R., Van Den Eeden, S. K., Willis, A. W., & Tanner, C. (2018 ). Occurrence of Parkinson’s illness throughout The United States and Canada. Npj Parkinson’s Illness, 4( 1 ), 21.

Nutt J. G. (2000 ). Action to L-dopa in PD: the lengthy as well as the except it. Neurology, 54( 10 ), 1884– 1885. doi.org/10.1212/wnl.54.10.1884

Oeckl, P., Hengerer, B., & Ferger, B. (2014 ). G-protein coupled receptor 6 shortage changes striatal dopamine as well as cAMP focus as well as decreases dyskinesia in a computer mouse design of Parkinson’s illness. Speculative neurology, 257, 1– 9. doi.org/10.1016/j.expneurol.2014.04.010

Extreme Spasticity. (2020 ). lioresal.com/severe-spasticity/.

Venderová, K., Růzicka, E., Vorísek, V., & Visnovský, P. (2004 ). Study on marijuana usage in Parkinson’s illness: subjective renovation of electric motor signs. Activity conditions: main journal of the Activity Problem Culture, 19( 9 ), 1102– 1106. doi.org/10.1002/mds.20111

Wang, M., Wang, Y.-H., Avula, B., Radwan, M. M., Wanas, A. S., Mehmedic, Z., van Antwerp, J., ElSohly, M. A., & Khan, I. A. (2017 ). Measurable Resolution of Cannabinoids in Marijuana as well as Marijuana Products Making Use Of Ultra-High-Performance Supercritical Liquid Chromatography as well as Diode Array/Mass Spectrometric Discovery. Journal of Forensic Sciences, 62( 3 ), 602– 611. doi.org/10.1111/1556-4029.13341

source

Comments are closed, but trackbacks and pingbacks are open.